6. パーキンソン病 Parkinson disease Clinical trials / Disease details

臨床試験数 : 2,307 / 薬物数 : 2,007 - (DrugBank : 349) / 標的遺伝子数 : 188 - 標的パスウェイ数 : 199

241 trials found

diseases per page:

Showing 1 to 10 of 241 diseases

Filter by

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	EUCTR2020-002754-24-DE (EUCTR)	19/01/2022	14/06/2021	Clinical study in early PD patients to investigate the effect of Opicapone 50mg or Levodopa 100 mg i ...	A randomized, parallel group, multicentre, multinational, prospective, open-label exploratory study ...	Parkinson's Disease (PD) MedDRA version: 20.0;Level: HLT;Classification code 10034005;Term: Parkinso ...	Trade Name: Ongentys 50 mg hard capsules INN or Proposed INN: Ongentys 50 mg hard capsules Other descrip ...	Bial - Portela & Ca, S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 4	Portugal;Spain;Germany;United Kingdom;Italy
2	NCT05094050 (ClinicalTrials.gov)	January 18, 2022	20/10/2021	Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult ...	Parkinson's Disease: A Comparative Study of Levodopa and CarbidopaBioavailability Following Foslevod ...	Parkinson's Disease	Drug: ABBV-951	AbbVie	NULL	Active, not recruiting	30 Years	N/A	All	16	Phase 1	United States
3	NCT05083260 (ClinicalTrials.gov)	January 4, 2022	23/9/2021	NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa	A Double-Blind, Placebo-Controlled, Safety, Tolerability, and Pharmacokinetics Study in Parkinson's ...	Parkinson Disease	Drug: NE3107;Drug: placebo	BioVie Inc.	NULL	Completed	30 Years	80 Years	All	46	Phase 1/Phase 2	United States
4	NCT04952194 (ClinicalTrials.gov)	January 1, 2022	3/6/2021	Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease	Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease	Parkinson Disease	Drug: Stalevo;Drug: Carbidopa and Levodopa Controlled Release Tablets	Second Affiliated Hospital, School of Medicine, Zhejiang University	NULL	Recruiting	30 Years	70 Years	All	180	Phase 4	China
5	EUCTR2019-004235-23-SE (EUCTR)	13/11/2021	24/08/2021	Parkinson's Disease: An extension of Study M15-741 evaluating the safety and tolerability of ABBV-95 ...	An open-label extension of Study M15-741 to evaluate the safety and tolerability of 24-hour daily ex ...	Parkinson's Disease MedDRA version: 20.0;Level: PT;Classification code 10061536;Term: Parkinson's di ...	Product Name: Foscarbidopa and Foslevodopa Product Code: ABBV-951 INN or Proposed INN: Foslevodopa Other ...	Abbvie Deutschland GmbH & Co. KG	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	130	Phase 3	United States;Canada;Denmark;Australia;Russian Federation;Germany;Netherlands;Italy;United Kingdom;J ...
6	NCT05128175 (ClinicalTrials.gov)	October 29, 2021	27/10/2021	Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and F ...	An Open-label, Balanced, Randomized, Five-treatment, Five-period, Five-sequence, Multiple Oral Dose, ...	Parkinson Disease	Drug: WD-1603 Carbidopa-Levodopa Extended-Release Tablets	Shanghai WD Pharmaceutical Co., Ltd.	NULL	Recruiting	18 Years	45 Years	All	15	Phase 1	India
7	NCT05036473 (ClinicalTrials.gov)	October 12, 2021	10/8/2021	A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With P ...	A Phase II Randomized, Parallel, Double-blind, Placebo-controlled, Multi-center Clinical Trial of th ...	Parkinson Disease	Drug: WD-1603 Carbidopa-Levodopa Extended-Release Tablets;Drug: Placebo	Shanghai WD Pharmaceutical Co., Ltd.	NULL	Recruiting	30 Years	75 Years	All	40	Phase 2	China
8	EUCTR2020-002754-24-IT (EUCTR)	09/09/2021	30/08/2021	Clinical study in early PD patients to investigate the effect of Opicapone 50mg or Levodopa 100 mg i ...	A randomized, parallel group, multicentre, multinational, prospective, open-label exploratory study ...	Parkinson's Disease (PD) MedDRA version: 20.0;Level: HLT;Classification code 10034005;Term: Parkinso ...	Trade Name: SINEMET 100 mg + 25 mg tablets Product Name: SINEMET 100 mg + 25 mg compresse Product Code ...	BIAL-Portela & Ca, S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 4	Portugal;Spain;Germany;United Kingdom;Italy
9	EUCTR2020-003372-41-ES (EUCTR)	27/07/2021	09/06/2021	Investigating the DopaFuse® Delivery System in Parkinson’s Disease Patients. Assessing safety, effec ...	Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa via th ...	Motor symptoms in Parkinson’s Disease. MedDRA version: 20.0;Level: PT;Classification code 10061536;T ...	Product Name: DopaFuse Delivery System INN or Proposed INN: levodopa Other descriptive name: LEVODOPA I ...	SynAgile Corporation	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	24	Phase 1;Phase 2	Spain;Luxembourg;Italy
10	EUCTR2020-002754-24-ES (EUCTR)	06/07/2021	09/06/2021	Clinical study in early PD patients to investigate the effect of Opicapone 50mg or Levodopa 100 mg i ...	A randomized, parallel group, multicentre, multinational, prospective, open-label exploratory study ...	Parkinson's Disease (PD) MedDRA version: 20.0;Level: HLT;Classification code 10034005;Term: Parkinso ...	Trade Name: Ongentys 50 mg hard capsules INN or Proposed INN: Ongentys 50 mg hard capsules Other descrip ...	Bial - Portela & Ca, S.A.	NULL	Authorised-recruitment may be ongoing or finished			Female: yes Male: yes	100	Phase 4	Portugal;Spain;Germany;United Kingdom;Italy

First Previous1 2 3 4 5…25Next Last